Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action

Brain Research

Volumn 870, Issue 1-2, 2000, Pages 157-162

  Nomura, Tamotsu ^a   Nishizaki, Tomoyuki ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hippocampus; Long lasting facilitation; Neurotransmission; Nicotinic acetylcholine receptor; Nootropic agent

Indexed keywords

ALPHA BUNGAROTOXIN; AMPA RECEPTOR; ANIRACETAM; CHOLINERGIC RECEPTOR; MECAMYLAMINE; NEFIRACETAM; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; NOOTROPIC AGENT; PIRACETAM;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DENTATE GYRUS; GENETIC TRANSCRIPTION; HIPPOCAMPUS; MALE; NEUROTRANSMISSION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; XENOPUS;

ANIMALS; BUNGAROTOXINS; GENE EXPRESSION; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MECAMYLAMINE; MEMBRANE POTENTIALS; NEURONS; NICOTINIC ANTAGONISTS; NOOTROPIC AGENTS; OOCYTES; PATCH-CLAMP TECHNIQUES; PIRACETAM; PYRROLIDINONES; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; SYNAPTIC TRANSMISSION; XENOPUS;

EID: 0034617413     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02417-3     Document Type: Article

References (22)

1. Boulter J., Hollmann M., O'Shea-Greenfield A., Hartley M., Deneris E., Maron C., Heinemann S. Molecular cloning and functional expression of glutamate receptor subunit genes. Science. 249:1990;1033-1037.
2. 125I]α-bungarotoxin. J. Neurosci. 5:1985;1307-1315.
3. Dominguez del Toro E., Juiz J.M., Peng X., Lindstrom J., Criado M. Immunocytochemical localization of the α7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J. Comp. Neurol. 349:1994;325-342.
4. Dunett S. Cholinergic grafts, memory and ageing. Trends Neurosci. 14:1991;371-384.
5. Gouliaev A.H., Senning A. Piracetam and other structurally related nootropics. Brain Res. Rev. 19:1994;180-222.
6. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
7. Hiramatsu M., Shiotani T., Kameyama T., Nabeshima T. Effects of nefiracetam on amnesia animal models with neuronal dysfunction. Behav. Brain Res. 83:1997;107-115.
8. Kolta A., Lynch G., Ambros-Ingerson J. Effects of aniracetam after LTP induction are suggestive of interactions on the kinetics of the AMPA receptor channel. Brain Res. 788:1998;269-286.
9. McGehee D.S., Health M.J.S., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
10. Molnar P., Gaal L., Horvath C. The impairment of long-term potentiation in rats with medial septal lesion and its restoration by cognition enhancers. Neurobiol. Rep. 2:1994;255-266.
11. Nishizaki T., Matsuoka T., Nomura T., Matsuyama S., Watabe S., Shiotani T., Yoshii M. 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam. Brain Res. 826:1999;281-288.
12. Nishizaki T., Matsuoka T., Nomura T., Sumikawa K., Shiotani T., Watabe S., Yoshii M. Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways. Mol. Pharmacol. 53:1998;1-5.
13. 2+-permeable AMPA receptors by interacting with a CaMKII pathway. Mol. Brain Res. 67:1999;184-189.
14. Nishizaki T., Matsuoka T., Nomura T., Enikolopov G., Sumikawa K. Arachidonic acid induces a long-lasting facilitation of hippocampal synaptic transmission by modulating PKC activity and nicotinic ACh receptors. Mol. Brain Res. 69:1999;263-272.
15. Tang C.-M., Shi Q.-Y., Katchman A., Lynch G. Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science. 254:1991;288-290.
16. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L. The distribution of α2, α3, α4 and β2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization study in rat. J. Comp. Neurol. 284:1989;314-335.
17. Watabe S., Yamaguchi H., Ashida S. DM-9384, a new cognition-enhancing agent, increase the turnover of components of the GABAergic system in the rat cerebral cortex. Eur. J. Pharmacol. 238:1993;303-309.
18. Wilkie G.I., Hutson P.H., Stephens M.W., Whiting P., Wonnacott S. Hippocampal nicotinic autoreceptors modulates acetylcholine release. Biochem. Soc. Trans. 21:1993;429-431.
19. Wonnacott S. Neuronal nicotinic receptors: functional correlates of ligand binding sites. Biochem. Soc. Trans. 19:1991;121-124.
20. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
21. Woodruff-Pak D.S. Nefiracetam ameliorates learning deficits in older rabbits and may act via the hippocampus. Behav. Brain Res. 83:1997;179-184.
22. Woodruff-Pak D.S., Hinchliffe R.M. Mecamylamine- and scopolamine-induced learning impairment: ameliorated by nefiracetam. Psychopharmacology. 131:1997;130-139.